PAI-1 antisense oligonucleotides (Angioblast)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamePAI-1 antisense oligonucleotides (Angioblast)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionPlasminogen activator inhibitor 1 inhibitors
TargetsPlasminogen activator inhibitor 1
Therapy Area/IndicationsVascular System InjuriesHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMesoblast Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMesoblast Inc
Active IndicationsN/A
Inactive IndicationsVascular System InjuriesHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A